Premier Biotech's COVID-19 antibody test authorized by FDA

LabPulse.com staff writers
Jun 8, 2020
2020 05 15 21 21 3306 Green Traffic Light 400

Premier Biotech has garnered an emergency use authorization from the U.S. Food and Drug Administration (FDA) for its COVID-19 antibody test.

Manufactured by Hangzhou Biotest Biotech, the test provides qualitative detection and differentiation of immunoglobulin M and immunoglobulin G antibodies against SARS-CoV-2 in whole blood, serum, or plasma. It can provide results in 10 minutes, Premier Biotech said.

The firm plans to distribute the kit to all 50 U.S. states.

Latest in Infectious
Hepatitis C Virus Social
CDC awards contract to Quest Diagnostics to assess hepatitis C burden
December 7, 2023
Antibiotic Resistant Bacteria Social
U.K. researchers use deep learning to develop rapid antimicrobial resistance test
December 1, 2023
Sepsis Bacteria Social
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
November 22, 2023
Bacteria Blood Sepsis Social
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
November 20, 2023
Related Stories
2020 04 14 18 47 7275 Lab Blood Tubes 400
Infectious
Red Cross to test donated blood for COVID-19 antibodies
2020 05 15 21 21 3306 Green Traffic Light 400
Collaboration
ChromaCode lands clearance for high-definition PCR coronavirus test
2019 12 13 21 10 9322 Dna Sequencing 400
Sequencing
FDA grants first clearance of sequencing-based COVID-19 test to Illumina
2020 04 13 23 36 0760 Lab 2019 Coronavirus Test 400
Emergency Use Authorization
Arbor Vita launches open-platform COVID-19 test
More in Infectious
CDC awards contract to Quest Diagnostics to assess hepatitis C burden
Quest Diagnostics has been awarded a multiyear contract by the U.S. Centers for Disease Control and Prevention (CDC) to assess the burden of hepatitis C virus (HCV) in the U.S.
December 7, 2023
Hepatitis C Virus Social
U.K. researchers use deep learning to develop rapid antimicrobial resistance test
Researchers are hailing progress toward more rapid detection of antimicrobial resistance (AMR), with a susceptibility test returning results in 30 minutes.
December 1, 2023
Antibiotic Resistant Bacteria Social
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.
November 22, 2023
Sepsis Bacteria Social
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
Oxford, U.K.-based Oxford Nanopore Technologies and Boston-based infectious disease diagnostics firm Day Zero Diagnostics have announced a partnership to develop an end-to-end solution for the diagnosis of bloodstream infections.
November 20, 2023
Bacteria Blood Sepsis Social
Cytovale raises $84M in series C funding
Medical technology firm Cytovale has raised $84 million in a series C financing round that the firm says it will use to expand the commercialization of its 10-minute IntelliSep test.
November 16, 2023
Money Hundred Bills Social
Illumina launches pricing program for pathogen sequencing tools in LMICs
Illumina has launched its Global Health Access Initiative program to provide pathogen sequencing tools at lower prices in low- and middle-income countries (LMICs).
November 13, 2023
Infectious Diseases Research Social
AI model could predict viral mutation, aid vaccine design
Researchers have developed a new artificial intelligence (AI) tool which they say could help predict new viral variants before they emerge.
October 31, 2023
Sequencing Virus Social
WHO launches expert review panel for NTD diagnostics
The World Health Organization (WHO) has created a pilot scheme for an expert review panel for diagnostic products as part of its program for neglected tropical diseases (NTDs).
October 13, 2023
Infectious Diseases Research Social
NIH researchers develop PCR assay for easier diagnosis of river blindness
U.S. National Institutes of Health (NIH) researchers have developed a new PCR assay to detect Onchocerca volvulus, the parasite that causes onchocerciasis, or river blindness, and are working to adapt it for easier field diagnosis of the disease.
October 9, 2023
Test Tubes Social
BioMérieux subsidiary secures DoD contract for infectious disease testing system
BioFire Defense, a subsidiary of BioMérieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.
September 29, 2023
Test Tube Liquid Sample Social
Study shows malaria drug resistance occurring in Horn of Africa
Malaria parasites in eastern Africa have developed resistance to artemisinins, essential first-line drugs used in combination therapies, jeopardizing the progress made in recent decades against the disease.
September 29, 2023
Plasmodium Falciparum Malaria Cdc Social
Day Zero Diagnostics to use $16M in funding to improve management of antibiotic-resistant infections
Day Zero Diagnostics recently raised $16 million to fund the application of whole-genome sequencing and artificial intelligence to antibiotic-resistant infections, facilitating the firm’s goal of changing how infectious diseases are diagnosed.
September 28, 2023
Dna Sequencing2
Page 1 of 148
Next Page